Product
MN-001
2 clinical trials
7 indications
Indication
Diabetes MellitusIndication
Type 2Indication
HypertriglyceridemiaIndication
Nonalcoholic Fatty Liver DiseaseIndication
Non-alcoholic SteatohepatitisIndication
Non-alcoholic Fatty Liver DiseaseIndication
HypercholesterolemiaClinical trial
A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of MN-001 in Patients Diagnosed With Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and HypertriglyceridemiaStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
An Open-Label Study To Evaluate The Efficacy, Safety, Tolerability and PK of MN-001 (Tipelukast) on HDL Function and Serum Triglyceride Levels in NASH and Non-Alcoholic Fatty Liver Disease (NAFLD) Subjects With HypertriglyceridemiaStatus: Completed, Estimated PCD: 2018-05-30